Showing Results for
- Academic Journals (581)
Search Results
- 581
Academic Journals
- 581
- Search Terms:
- 1From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Economic implications of chemotherapy-induced febrile neutropenia (FN) in European and Australian clinical practice are largely unknown. Methods Data were obtained from a European (97%) and Australian...
- 2From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground It has previously been shown that indirubin derivative E804 (IDR-E804) blocks signal transducer and activator of transcription-3 signaling in human breast and prostate cancer cells and inhibits Src kinase...
- 3From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Increased glycolytic activity is a hallmark of cancer, allowing staging and restaging with .sup.18F-fluorodeoxyglucose-positron-emission-tomography (PET). Since interim-PET is an important prognostic tool in...
- 4From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Knowledge about signaling pathways in malignant cells may provide prognostic and diagnostic information in addition to identify potential molecular targets for therapy. B-cell receptor (BCR) and co-receptor...
- 5From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Esophageal squamous cell carcinoma (ESCC) shows geographic variations in incidence, with high incidences (>50/10.sup.5 person-years) in central Asia, including North Eastern Iran (Golestan) and Northern...
- 6From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Despite recent advances in the treatment of hepatocellular carcinoma (HCC), the chemotherapy efficacy against HCC is still unsatisfactory. The mammalian target of rapamycin (mTOR) has been emerged as an...
- 7From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Elderly patients are more vulnerable to toxicity from chemotherapy. Activating epidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC) are associated with enhanced response to...
- 8From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground G-protein-coupled estrogen receptor (GPER/GPR30) was reported to bind 17[beta]-estradiol (E.sub.2), tamoxifen, and ICI 182,780 (fulvestrant) and promotes activation of epidermal growth factor receptor...
- 9From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground MicroRNAs (miRNAs) and their role during tumor development have been studied in great detail during the last decade, albeit their expression pattern and regulation during normal development are however not...
- 10From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Hodgkin lymphoma (HL) is one of the most frequent lymphoma in the western world. Despite a good overall prognosis, some patients suffer relapsing tumors which are difficult to cure. Over a long period...
- 11From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground One-third of breast cancers display amplifications of the ERBB2 gene encoding the HER2 kinase receptor. Trastuzumab, a humanized antibody directed against an epitope on subdomain IV of the extracellular...
- 12From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground The epidermal growth factor receptor (EGFR) is a potential target of anticancer therapy in gastric cancer. However, its prognostic role in metastatic gastric or gastroesophageal junction (GE) cancer has not...
- 13From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Abnormal NF-κB2 activation has been implicated in the pathogenesis of multiple myeloma, a cancer of plasma cells. However, a causal role for aberrant NF-κB2 signaling in the development of plasma cell...
- 14From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Chemotherapy is the mainstay of non-Hodgkin lymphoma (NHL) treatment. Based on expert opinion, the use of radiotherapy (RT) is currently preferred in some institutions as consolidative treatment for patients...
- 15From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Lung cancer is the leading cause of cancer-related death worldwide. Epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI) is used for the patients with EGFR-mutant lung cancer. Recently,...
- 16From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Historically, the median overall survival for follicular lymphoma (FL) has been considered to be 9-10 years, and no treatment had ever prolonged this time period. Studies conducted more than 20 years ago...
- 17From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Male breast cancer (MBC) is an uncommon and relatively uncharacterised disease accounting for <1% of all breast cancers. A significant proportion occurs in families with a history of breast cancer and in...
- 18From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Lung cancer in young patients (less or equal to 45 years) is uncommon and has clinical characteristics different from that in older patients. We investigated the outcomes and prognostic factors of young...
- 19From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma (ALK+ ALCL) is a T cell lymphoma defined by the presence of chromosomal translocations involving the ALK tyrosine kinase gene. These...
- 20From: BMC Cancer. (Vol. 12) Peer-ReviewedBackground Epidermal growth factor receptor (EGFR) signaling plays an important role in non-small cell lung cancer (NSCLC) and therapeutics targeted against EGFR have been effective in treating a subset of patients...